下呼吸道鲍曼不动杆菌感染患者对亚胺培南、美罗培南和头孢哌酮舒巴坦耐药的易感因素分析

doi:10.3969/j.issn.10073205.2019.03.019

河北医科大学学报

下呼吸道鲍曼不动杆菌感染患者对亚胺培南、美罗培南和头孢哌酮舒巴坦耐药的易感因素分析

1.河北医科大学第二医院感染控制处，河北石家庄 050000；2.河北医科大学第二医院神经外科，河北石家庄 050000

出版日期:2019-03-25 发布日期:2019-03-20
作者简介:王黎一（1987-），女，河北石家庄人，河北医科大学第二医院主治医师，医学硕士，从事医院内感染及控制研究。
基金资助:
河北省医学科学研究重点课题(20180356)；河北省医学科学研究重点课题（20160113）；河北医科大学第二医院科学研究基金项目(2h2017040)

Evaluate on the risk factors of the antibiotic resistance caused by Acinetobacter baumannii pneumonia in Meropenem, Imipenem and CefperazoneSulbactam

1.Department of Infection Management, the Second Hospital of Hebei University, Shijiazhuang
050000, China; 2.Department of Neurosurgery, the Second Hospital of
Hebei University, Shijiazhuang 050000, China

Online:2019-03-25 Published:2019-03-20

摘要/Abstract

摘要： ［摘要］〓
〖HTH〗目的〖HTSS〗〖KG*2〗研究影响下呼吸道鲍曼不动杆菌（Acinetobacter baumannii,AB）感染患者对亚胺培南（Imipenem,IPM）、美罗培南（Meropenem,MEM）和头孢哌酮舒巴坦（CefperazoneSulbactam,SCF）耐药的易感因素。
〖HTH〗方法〖HTSS〗〖KG*2〗收集下呼吸道感染患者的痰标本，分离出鲍曼不动杆菌感染944株，其中931株进行了IPM药物敏感试验，712株进行了MEM药物敏感试验，887株进行了SCF药物敏感试验，根据药物敏感试验结果分为耐药组和非耐药组，比较其多重耐药鲍曼不动杆菌（multidrugresistant Acinetobacter baumannii，MDRAB）的检出率，比较不同性别、是否侵入性操作、是否泌尿道插管、是否气管插管、是否气管切开、是否使用呼吸机、是否进行中心静脉插管、是否手术、是否入住外科、是否入住ICU、住院次数、感染前住院时间、感染季节等不同环境条件下的耐药性，并进行Logistic回归分析。
〖HTH〗结果〖HTSS〗〖KG*2〗耐药组IPM、MEM和SCF的MDRAB检出率远高于不耐药组，差异均有统计学意义（P＜005）。无论在IPM组、MEM组还是SCF组，男性、有侵入性操作、有泌尿道插管、有气管插管、有气管切开、应用呼吸机、行中心静脉插管、行手术、入住外科、入住ICU者均较女性、无侵入性操作、无泌尿道插管、无气管插管、无气管切开、未使用呼吸机、未行中心静脉插管、未行手术、未入住外科、未入住ICU者耐药检出率高，差异有统计学意义（P＜005）。Logistic回归显示：使用呼吸机是促进AB对3种药物耐药概率升高的共同院内感染防控因素（P＜005）；男性、入住ICU、感染前使用抗生素≥5 d和冬春季均是增加AB对IPM和MEM 2种药物耐药概率的共同危险因素（P＜005）；入住外科和住院1次均是增加AB对IPM耐药的独立危险因素（P＜005）。
〖HTH〗结论〖HTSS〗〖KG*2〗应针对各种抗生素耐药发生的高危人群、高发季节和高发时段设计院内感染防控措施，缩短使用抗生素时间，重视早期细菌学检测，提高入院早期送检率，有效控制细菌对抗生素耐药的发生和发展。

关键词: 鲍氏不动杆菌, 下呼吸道感染, 多重耐药

Abstract: ［Abstract］ Objective〖HTSS〗〓To evaluate the risk factors of the antibiotic resistance of Imipenem(IPM), Meropenem(MEM) and CefperazoneSulbactam(SCF) among the Acinetobacter baumannii(AB) pneumonia.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓A total of 944 specimens from lower respiratory tract with acinetobacter baumannii pneumonia were identified: 931, 712 and 887 were subjected to antimicrobial susceptibility testing in IPM, MPM and SCF, respectively. The difference in the rate of multidrugresistant Acinetobacter baumannii(MDRAB) and the clinical characteristics between the dichotomized resistant group and nonresistant group in the three antimicrobial susceptibility testing were analyzed, respectively. Then we used Logistic regression analysis to evaluate the risk factors.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓The MDRAB rates of the resistant group were higher than the nonresistant group in the three antibacterial agents(P＜005). There were significant differences in sex, the use of invasive operation, urinary tract intubation, trachea cannula, tracheotomy, ventilator, central venous catheter, surgery, internal or surgical department, intensive care unit, times of hospitalization, hospital stays and season between the dichotomized resistant group and nonresistant group in IPM, MEM and SCF(P＜005). Logistic regression analysis suggested that the use of ventilator before delivery could increase the risk of these three antibioticresistance(P＜005). While ABpneumonia patients in men, intensive care unit, the antibioticusedays≥5 d and SpringWinter could be easily resistant to both IPM and MEM(P＜005). And resistance to IPM may easily happened in surgical department and only one timehospitalization（P＜005）.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓he prevention and control measures should be designed according to the highrisk population, the highincidence season and the highoccurrence period of each kind of drugsensitive drug resistance, so as to shorten the time of antibiotic use, attach importance to the daily bacterial detection, improve the early detection rate at admission, and effectively control the occurrence and development of bacterial resistance to antibiotics.

Key words: Acinetobacter baumannii, lower respiratory tract infections; , multidrugresistant

王黎一1，曹旭华2*，史利克1，王〓悦1. 下呼吸道鲍曼不动杆菌感染患者对亚胺培南、美罗培南和头孢哌酮舒巴坦耐药的易感因素分析[J]. 河北医科大学学报, doi: 10.3969/j.issn.10073205.2019.03.019.

WANG Liyi, CAO Xuhua2*, SHI Like1, WANG Yue1. Evaluate on the risk factors of the antibiotic resistance caused by Acinetobacter baumannii pneumonia in Meropenem, Imipenem and CefperazoneSulbactam[J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.10073205.2019.03.019.

[1]	苗勤1，刘海涛1*，何敬堂2，方玲1，于大巍1，白泽梅3. 多重耐药目标菌主动筛查联合模拟防控训练的干预效果研究[J]. 河北医科大学学报, 2019, 40(11): 1327-1331.
[2]	杨宝财1，苗勤2*，刘海涛2，方玲2，于大巍2，何敬堂3. 我院ICU多重耐药鲍曼不动杆菌聚集性病例与环境污染调查分析[J]. 河北医科大学学报, 2019, 40(11): 1317-1321.
[3]	李海涛，张鲁涛，李〓帅，王伯丽，齐天杰，李宏林. 基因组学研究Csu基因簇在生物被膜生成过程中的作用[J]. 河北医科大学学报, 2017, 37(8): 869-872.
[4]	邱万臣1，杨〓靖2，时东彦2*，范士英2. 应用Carba NP方法检测耐碳青霉烯类抗生素鲍曼不动杆菌和铜绿假单胞菌[J]. 河北医科大学学报, 2017, 37(7): 847-850.
[5]	李继红，时东彦*，袁〓玥，李志荣. 2 253株鲍曼不动杆菌耐药监测及临床价值评估[J]. 河北医科大学学报, 2017, 37(12): 1439-1442,1447.
[6]	李〓帅1，张鲁涛1，李海涛1，王伯丽1，史晶晶2. 转录组学研究群体感应系统在生物被膜中的独特表达#br#[J]. 河北医科大学学报, 2017, 37(11): 1241-1243,1252.
[7]	冯〓锐，郑〓颖，高亚乾，李〓东，刘〓江，杜文力*. 我院鲍曼不动杆菌耐药率与同期抗菌药物用药频度相关性分析[J]. 河北医科大学学报, 2017, 37(1): 72-75.
[8]	郑毅. 集束干预护理在RICU多重耐药鲍曼不动杆菌感染患者中的应用[J]. , 2015, 36(1): 99-99.
[9]	孙静娜;刘青松;刘泽世;赵帅;王国欣;张征. 多重耐药及泛耐药鲍曼不动杆菌外排泵基因adeB的研究[J]. , 2014, 35(10): 1166-1166.
[10]	丁力. 联合用药对鲍曼不动杆菌体外抗菌活性研究[J]. , 2012, 33(3): 369-369.
[11]	丁力;王宪德. 抗生素联合舒巴坦对抗鲍曼不动杆菌的实验分析[J]. , 2012, 33(2): 225-225.

下呼吸道鲍曼不动杆菌感染患者对亚胺培南、美罗培南和头孢哌酮舒巴坦耐药的易感因素分析

Evaluate on the risk factors of the antibiotic resistance caused by Acinetobacter baumannii pneumonia in Meropenem, Imipenem and CefperazoneSulbactam

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价